SELLAS Life Sciences Group, Inc. (SLS)

5.53 +0.25 (+4.73%) USD  |  NASDAQ  |  Mar 06, 16:00
5.52 -0.01 (-0.18%) After-Hours: 20:00
More

SELLAS Life Sciences Group Price to Book Value (3y Mean)

Price to Book Value (3y Mean) Chart

View Price to Book Value (3y Mean) for SLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price to Book Value (3y Mean) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Price to Book Value (3y Mean) Range, Past 5 Years

View Price to Book Value (3y Mean) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value (3y Mean) Benchmarks

View Price to Book Value (3y Mean) Benchmarks
Start Trial
Amicus Therapeutics, Inc. Upgrade
Vanda Pharmaceuticals, Inc. Upgrade
GT Biopharma, Inc. --
ADMA Biologics, Inc. Upgrade
Lyell Immunopharma, Inc. Upgrade